Navigation Links
Fluorescent probe for oral cancer
Date:8/4/2010

UC Davis researchers have developed a laser probe for the early detection of oral cancer. A trial with human subjects shows that the device could also be used during surgery to locate the edges of a tumor.

Approximately 43,000 people in the U.S. are diagnosed with tumors of the mouth, pharynx and larynx each year. The main risk factor is smoking, but a recent rise in cases has been linked to human papillomavirus. Most cases are not diagnosed until the cancer has reached an advanced stage.

"There's a lot out there about breast, prostate and brain cancer, but people are not so aware about oral cancer and its devastating consequences," said Laura Marcu, a professor of biomedical engineering at UC Davis. "People don't think to look for it, and there isn't any routine screening."

Marcu's laboratory collaborated with Dr. Gregory Farwell's group in the Department of Otolaryngology at the UC Davis Cancer Center to develop the fiber-optic probe.

The probe stimulates molecules in the patient's tissues with a laser. Some of these molecules naturally respond by re-emitting fluorescent light. The device rapidly detects and analyzes this light using a process called "time-resolved fluorescence spectroscopy" (TR-LIFS), which provides information about the types of molecules present.

During surgery, blood can distort the intensity of the fluorescence signal but not its duration. By using sensitive measurements of the change in fluorescence over time, surgeons can see the tumor margins even as they are cutting the tissue.

Based on encouraging results in animal tests, Marcu and Farwell's team recruited nine human volunteers from among patients who arrived at the UC Davis Medical Center for surgical therapy of the mouth, throat and larynx. They compared readings from spectroscopy with biopsy samples from the same locations and found that the probe could accurately diagnose the cancer in the surgical environment.

The probe is similar to one that Marcu has already developed for use with brain tumors. In clinical trials, surgeons have used her technology to delineate the margins of tumors during surgery.

Details of the human oral cancer study were published in the June issue of the journal Otolaryngology - Head and Neck Surgery. The pilot study in patients was supported in part by the Cancer Center and the Clinical and Translational Science Center at the UC Davis School of Medicine and the UC Davis Center for Biophotonics Science and Technology.


'/>"/>

Contact: Andy Fell
ahfell@ucdavis.edu
University of California - Davis - Health System
Source:Eurekalert

Related medicine news :

1. Replacing hydrogen in fluorescent dyes improves detection ability, stability and shelf life
2. Fluorescent probes light up cancerous tumors
3. Study Probes Causes of Anger in Returning U.S. Soldiers
4. PET scanning probes reveal different cell function within the immune system
5. Lab that probes genetic clues to disease is poised for major expansion
6. Nanoscale stealth probe slides into cell walls seamlessly, say Stanford engineers
7. Scientists develop the first model for investigating the origins of testicular cancer in humans
8. New imaging technique could help physicians ease the aftermath of breast cancer
9. Scientists develop designer protein, opening new door in cancer research
10. Oral contraceptive use associated with increased risk of breast cancer
11. Purdue-IU team uncovers potential prostate cancer marker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , ... announced it has partnered with WALLIX to expand its solution to help ... , There are a number of ways to address the authentication requirements within ...
(Date:7/24/2017)... ... July 24, 2017 , ... A CDC study shows that, although people are taking more ... 18 to 29), had at least one case of sunburn within the past year. It’s ... people to ignore the issue. However, only recently have people become conscientious of the risks ...
(Date:7/24/2017)... ... July 24, 2017 , ... The ... Harbor, MD. This year's theme focuses on the new ISO/IEC 17025 standards. This ... and integrity in testing and calibration will be changed. , As an ...
(Date:7/24/2017)... ... 24, 2017 , ... Paul Vitenas, MD, FACS is excited to report that ... to attend Allergan’s recent meeting with their Plastics Advisory Board. As one of the ... is bringing a newly defined structure to the aesthetics market. Dr. Vitenas , ...
(Date:7/24/2017)... ... July 24, 2017 , ... Committed ... they have enrolled over 100,000 children in their treatment program. Clubfoot is a ... in areas where treatment is limited or non-existent. Without intervention, these children are ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... founder of Echenberg Institute, is announcing a new safe and effective at-home ... and other painful pelvic pain conditions such as pelvic floor dysfunction, vulvodynia, ... ... ... start-up company, VuVatech LLC, fills a void in the women,s wellness market ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
Breaking Medicine Technology: